Latest AI and machine learning research in hemophilia for healthcare professionals.
Glycogen synthase kinase-3β (GSK3β) has emerged as one of the most thoroughly validated therapeutic targets in modern drug discovery, with dysregulation implicated in neurodegenerative diseases, metabolic disorders, cancer, psychiatric conditions, and inflammatory pathologies. This review provides a comprehensive and critical overview of recent advances in GSK3β inhibitor design, encompassing ATP-...
Artificial Intelligence (AI) and Clinical Practice Guidelines (CPGs) both aim to support clinical decision-making but may provide conflicting suggestions. This manuscript presents a Guideline-Aligned Machine Learning (GAML) model to predict ondansetron administration at the end of anaesthesia, based on Gan et al.'s Fourth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting...
Postmenopausal females diagnosed with breast cancer who are undergoing aromatase inhibitor (AI) therapy often exhibit metabolic disturbances, which ma...
BACKGROUND: Metabolic dysfunction-associated steatohepatitis (MASH) has become a major global health burden yet effective pharmacological treatments r...
Immune checkpoint inhibitors (ICIs) represent a class of novel anticancer agents that enhance T cell-mediated recognition and elimination of tumor cel...
BACKGROUND: Epidermal growth factor receptor (EGFR) inhibitors and other targeted therapies frequently cause cutaneous toxicities, impairing patient q...
Per- and polyfluoroalkyl substances (PFAS) are persistent pollutants linked to breast cancer (BC), but their role in perineural invasion (PNI) of trip...
Scientific discovery is driven by the iterative process of observation, hypothesis generation, experimentation, and data analysis. Despite recent adva...
Immunotherapy has transformed cancer treatment but remains ineffective in many solid tumors, largely due to the immunosuppressive tumor microenvironme...
Pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis due to treatment resistance and an immunosuppressive, fibrotic microenvironment. Ferrop...
PURPOSE OF REVIEW: Immune checkpoint inhibitors (ICIs) have transformed cancer therapy, producing durable responses across multiple malignancies. Howe...
Glioblastoma multiforme (GBM) is an aggressive primary brain tumour that presents significant treatment challenges due to its complex pathology and he...
PURPOSE OF REVIEW: Myocarditis presents with heterogenous clinical manifestations and remains diagnostically challenging due to nonspecific biomarkers...
Precision oncology faces critical challenges in interpreting complex cellular signals and predicting drug responses across heterogeneous cancer enviro...
CONTEXT: Drug-resistant epilepsy (DRE) remains a major therapeutic challenge, affecting millions of patients globally who do not respond to convention...
Post-traumatic epilepsy (PTE) is a major long-term complication of traumatic brain injury (TBI), but early risk prediction remains imprecise. Radiomic...
Tubulointerstitial diseases represent a heterogeneous group of kidney diseases with diverse causes and overlapping histopathologic and immunophenotypi...
The nicotinamide adenine dinucleotide (NAD+)-dependent deacetylase Sirtuin 2 (SIRT2) plays a regulatory function in diverse cellular processes and has...
Hypercholesterolemia is a pivotal risk factor for cardiovascular diseases, and its effective management is critical to reducing cardiovascular event i...
Maternal mental health is associated with fetal neurodevelopment. Identifying effective treatments for maternal psychiatric conditions is a public hea...